Study: UAB Researchers Establish Optimal Immunosuppression Regimen for Pig-to-Human Kidney Transplants
January 26, 2024
January 26, 2024
BIRMINGHAM, Alabama, Jan. 26 (TNSres) -- The University of Alabama issued the following news:
Currently used Food and Drug Administration-approved transplant drugs -- with the addition of an also already FDA-approved complement inhibitor -- are the optimal immunosuppression regimen for pig-to-human kidney transplants, according to a landmark discovery by University of Alabama at Birmingham investigators. The peer-reviewed research is published today in the Journal of Clinical Invest . . .
Currently used Food and Drug Administration-approved transplant drugs -- with the addition of an also already FDA-approved complement inhibitor -- are the optimal immunosuppression regimen for pig-to-human kidney transplants, according to a landmark discovery by University of Alabama at Birmingham investigators. The peer-reviewed research is published today in the Journal of Clinical Invest . . .